antibiotic resistance

With the recent discovery of polymyxin-resistant infection here in the U.S., there's a renewed pledge among drug developers and the government to incentivize research for developing new antibiotics, previously a seemingly abandoned effort.
Dr. David Shlaes, my former colleague at Wyeth, is one of the world's premier experts in antibiotic research and development. He and I have co-written an opinion piece entitled "Stop Giving Antibiotics to Cows, Pigs, and Chickens Now," that was just published in STAT- the online science site of the Boston Globe. This issue is both timely and critical.
Dame Sally Davies, Britain's chief medical officer, has written to pharmacies and GPs warning them to use correct medical practices when treating the sexually transmitted bacterial infection gonorrhea, but too late Somehow, the UK ended up getting three years behind us in treating the infection properly. This is no laughing matter. Thanks to bacterial resistance, we are now down to one drug that still cures the infection. Misusing it, as was done in the UK, will accelerate the resistance problem, and could leave us with no options to cure a very common STD.
The battle of medicine vs. bacteria has been going quite poorly for more than two decades, primarily due to antibiotic resistance. The last thing we need is giving these bugs another edge. But in China, a newly-discovered gene can spread to many types of bacteria, and render useless some antibiotics that are our last line of defense against unresponsive infections.
Some new, alarming information from the World Health Organization shows that we need a better understanding of how to correct the problem of antibiotic-resistant infections in humans. A large, multi-country survey revealed widespread confusion of how antibiotics should be used.
A CDC report card shows that doctors are prescribing antibiotics for flu patients at an alarmingly high rate, a trend that contributes to the spread of antibiotic resistance. However, physicians shouldn't shoulder all the blame, as pushy patients need to be held accountable, too.
Subway announced recently that it will begin a long initiative to phase out meat from animals fed antibiotics as a growth enhancer. It's a win for public health, but the reality is that basically anyone, anywhere can get Subway to do just about anything at this point if one screams loud enough.
Antibiotic resistance is back. Sixteen cases of "super-gonorrhea" have been identified in the U.K., "super" because it has become resistant to one of the two drugs in the cocktail that's used to treat the sexually transmitted disease. The chance of untreatable gonorrhea is not just a sci-fi movie premise.
Hospital-acquired infections in the U.S. have been known to affect more than 700,000 patients in a single year. A new report says some hospitals are combatting this problem by lining surfaces with copper, a practice that has ancient roots. Bacteria resistance, yet, is suspected to be an undermining factor.
The ongoing debate over whether an antibacterial ingredient triclosan should be in soaps seems to have become an issue that's finally settled. It should not be in there and here are three reasons why.
Bad news from the CDC according to the July 23rd issue of the Morbidity and Mortality Weekly Report, a quarter of Americans expect an antibiotic prescription when they visit the doctor for a cold. Antibiotics do not fight viral infections like the common cold which is a
Back in May, the British government sponsored a review, headed up by former Goldman Sachs chief economist Jim O'Neill, regarding solutions to the antibiotic resistance crisis. O Neill s final report suggested that we de-link profits fr